NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NOVOS

NOVOS

Private
New York City, New YorkHealthcare & Life Scienceshttps://novoslabs.com/

Last Round

Strategic

Mar 5, 2026

Total Funding Raised

$3.15M

Company Overview

NOVOS is a longevity biotechnology company that develops science-backed nutraceuticals and personalized tools to support healthy aging and extend human healthspan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

longevity supplementsbiohackingbiological age testNAD+ precursorhealthspanDTC supplementspreventative healthanti-agingsubscription commercewellness appAI longevity coachhealth optimizationnutritional interventionbiological clock

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NOVOS Comparables

Compare NOVOS with similar companies based on industry and business-model similarity.

NOVOS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elysium Health
91%
DoNotAge
88%
Blueprint
87%

NOVOS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 5, 2026
Pre SeedOct 1, 2021

Key People

Founding team and executive leadership

Chris Mirabile

Founder, CEO

Founding Team

NOVOS Investors

Notable investors and investment history

NOVOS investors
InvestorRounds
Awesome People VenturesPre Seed
Uncommon DenominatorPre Seed
Longevitytech.fundPre Seed
Resolute VenturesPre Seed
Arkitekt VenturesPre Seed
Arkitekt VenturesPre Seed
Unilever VenturesStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 19, 2025

    Added The Big Fat Fix, a media startup, as a customer.

NOVOS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NOVOS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NOVOS's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range33
Year Founded2018
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.